News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
2021 US National Health Expenditures – Healthcare Economist
A paper inHealth AffairsbyMartin, Hartman, Benson, Catlin, and The National Health Expenditure Accounts Team (2022)finds that national health expenditures (NHE) rose but declined as a share of gross domestic product (GDP).Health care spending in the US grew 2.7 percent to reach $4.3 trillion in 2021
Can you emulate clinical trials with observational data? – Healthcare Economist
While randomized controlled trials (RCTs) are the gold standard of experimental research, there are some limitations. For instance, in some cases use of an RCT is not feasible (e.g., the sample size may be too small as in the case of rare disease), not ethical (e.g., if the previous standard of car
Increased access to articles in JAMA – Healthcare Economist
JAMAand it’s related sister journals as part of theJAMA Networkhave adopted a new publishing policy, moving the journal not entirely into the open access space, but one that will give individuals access to JAMA articles on other sites.JAMA editors write:Beginning in 2023,JAMAand all of the journals
1 in 8 deaths among non-elderly adults due to excessive alcohol use – Healthcare Economist
That is the finding from a paper byAfoakwah et al. (2022)inJAMA Open. The authors use 2015-2019 data from theNational Vital Statistics System,CDC WONDER, and the CDC’s Alcohol-Related Disease Impact (ARDI) Application for 58 alcohol-related causes of death. They find that:During the 2015-2019 study
Factors impacting state variation in health care spending – Healthcare Economist
AHealth Affairs Forefrontarticle byJohnson and Dieleman (2022)published last week using the Centers for Medicare and Medicaid Services’ (CMS’s)State Health Expenditure Accounts (SHEA)data. Aprevious studylooked at these data through 2014, but the recent publication updates this analysis through 20
Enhancing Oncology Model: Payment Methodology – Healthcare Economist
Back in July, I provided anoverview of the Enhancing Oncology Model (EOM). Today I build upon that post focusing largely on CMS’sEOM’s Payment Methodology. I use a Q&A format as well.What is the goal of EOM?According to CMS “EOM is a CMMI alternative payment model designed to advance health equity
How does a disease’s genetic complexity impact the likelihood of innovation? – Healthcare Economist
There was much hope that the advent of the Human Genome Project would lead to significant innovations as we began to learn more and more about how genes relate to disease. The ability of translating this knowledge to targeted therapies, however, is challenging. One key issue is how many genetic mu
Links – Healthcare Economist
Will Switzerland toaccept devices approved by FDA?What is asuperager?Marijuana substitutes for opioidsfor cancer patients?What is‘Brokenism’?Can you usedating apps to fight STDs?Quotation of the week:“Everything bad comes from change, but so does everything good”The Tablet
Hospital finances in 2022: Outlook is grim – Healthcare Economist
Based on some recent reports, hospital finances in 2022 look poor. Government cash infusions from COVID-19 were helpful during the pandemic but have largely disappeared. At the same time, costs for labor and supplies have risen. Adding on to these financial pressures is therecent rise in the numb
Exercising works – Healthcare Economist
Not a surprise, but the study approach used byKulaja et al. (2022)is interesting. They examine identical twins an examine how early adult exercise habits impact long term health outcomes. The abstract is below.…monozygotic (MZ) twin pairs discordant for health habits provide an interesting natural
How do increased rebates impact the rate of parallel imports in Europe? – Healthcare Economist
A paper byBirg (2022)aims to examine how mandatory increases in rebates for pharmaceutical products impacts the use of parallel imports. She uses a policy change from 2010 in Germany which mandated increased pharmaceutical rebates to identify the impact of this change.What are parallel imports?Paral
It gets better – Healthcare Economist
Many studies (e.g.,Okui 2020,Le Bon 2014,Blanchflower and Oswald 2009) have claimed that mental health exhibits a U shape where mental health decrease with a nadir at middle age and then increases as people grow into their elderly years. However, a recent study byDijk and Mierau (2022)finds that me
Should you adjust for baseline characteristics within randomized controlled trials? – Healthcare Economist
At first glance, one may think the answer is no. Randomization should insure that baseline characteristics are balanced across trial arms. In practice, however, sometimes baseline characteristics due differ somewhat by trial arm simply by chance, especially in smaller randomized controlled trials
What is DARWIN EU? – Healthcare Economist
Real-world data is becoming increasingly important as the amount of data generation increases as does the speed of data processing. In the US, the21st Century Cures Actwas enacted in December 2016 and mandated that the Food and Drug Administration (FDA) create a framework for evaluating the use of
HARmonized Protocol Template to Enhance Reproducibility (HARPER) – Healthcare Economist
Clinical trials have detailed study protocols and are registered on ClinicalTrials.gov. What level of details are needed for real-world data (RWD) analyses that aim to estimate treatment effects? In Europe, the European Medicines Agency (EMA) requires registration of many study protocols using a
Are Integrated Medicare Advantage Plans better? – Healthcare Economist
That is the questionPark, Langellier, and Meyers (2022)aim to estimate in their recentHealth Services Researchpublication. The authors use 2015-2017 data from the Centers for Medicare and Medicaid services and control for other differences between integrated and non-integrated Medicare Advantage (M
NHS Scotland to institute cost sharing? Pause access to new drugs? – Healthcare Economist
That is according to anarticle today from the BBC.NHS leaders in Scotland have discussed abandoning the founding principles of the service by having the wealthy pay for treatment.The discussion of a “two-tier” health service is mentioned in draft minutes of a meeting of Scotland’s NHS leaders in Sep